Načítá se...
How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
In past years, a diagnosis of bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplant (HCT) conferred nearly universal mortality secondary to lack of consensus for diagnostic criteria, poorly understood disease pathogenesis, and very few studies of therapeutic or suppo...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5270387/ https://ncbi.nlm.nih.gov/pubmed/27856461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-08-693507 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|